Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals

J Infect. 2022 Apr;84(4):579-613. doi: 10.1016/j.jinf.2022.01.002. Epub 2022 Jan 10.
No abstract available

Keywords: COVID-19; Chronic kidney disease; Cross reactivity; Delta; Haemodialysis; Omicron; SARS-CoV-2; Variants of Concern; antibody response; vaccination.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines*
  • COVID-19* / prevention & control
  • Glycoproteins
  • Humans
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines
  • Glycoproteins
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants